Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Jul 22 2026

· Issued by Oxygenta Pharmaceutical Limited

Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results for the quarter ended 30.06.20262. Any other item with the permission of chair

View Attachment

Earlier from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases